-
21
Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text
Article -
22
Dietary and lifestyle indices for hyperinsulinemia and odds of MAFLD in overweight and obese children and adolescents
Published 2025-02-01Subjects: Get full text
Article -
23
Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease; genetic; pnpla3; risk stratification; treatment…”
Get full text
Article -
24
Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study of NHANES...
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text
Article -
25
Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
Published 2025-01-01Subjects: Get full text
Article -
26
Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
Published 2025-01-01Subjects: “…Metabolic Dysfunction-Associated Steatotic Liver Disease…”
Get full text
Article -
27
The clinical value of serum sirtuin-1 concentration in the diagnosis of metabolic dysfunction-associated steatotic liver disease
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
28
Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
29
Serum dihomo-g-linolenic acid concentration as a potential novel noninvasive biomarker for liver steatosis detection in children
Published 2024-12-01Subjects: Get full text
Article -
30
Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Published 2025-01-01Subjects: Get full text
Article -
31
Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
Published 2025-01-01Subjects: Get full text
Article -
32
Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
Published 2025-01-01Subjects: Get full text
Article -
33
Body and mind: how obesity triggers neuropsychiatric and neurodegenerative disorders
Published 2025-01-01Subjects: Get full text
Article -
34
Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis
Published 2024-12-01Subjects: “…metabolic dysfunction-associated steatohepatitis…”
Get full text
Article -
35
Consistency analysis of two US techniques for evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
36
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
Published 2025-01-01Subjects: “…Metabolic dysfunction associated steatotic liver disease (MASLD)…”
Get full text
Article -
37
Establishing of a risk prediction model for metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
38
Metabolic dysfunction-associated fatty liver disease and risk of nephrolithiasis: a sizeable cross-sectional study
Published 2025-01-01Subjects: “…metabolic dysfunction-associated fatty liver disease…”
Get full text
Article -
39
Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults
Published 2025-01-01Subjects: “…biomarkers; fatty liver; metabolic dysfunction-associated steatotic liver disease; young adult; hepatic steatosis index…”
Get full text
Article -
40
Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway
Published 2025-01-01Subjects: “…metabolic dysfunction…”
Get full text
Article